Mainz Biomed N.V (MYNZ) Operating Expenses: 2019-2024
Historic Operating Expenses for Mainz Biomed N.V (MYNZ) over the last 6 years, with Dec 2024 value amounting to $19.3 million.
- Mainz Biomed N.V's Operating Expenses fell 20.18% to $6.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was $27.2 million, marking a year-over-year increase of 1.98%. This contributed to the annual value of $19.3 million for FY2024, which is 29.03% down from last year.
- Per Mainz Biomed N.V's latest filing, its Operating Expenses stood at $19.3 million for FY2024, which was down 29.03% from $27.2 million recorded in FY2023.
- In the past 5 years, Mainz Biomed N.V's Operating Expenses ranged from a high of $27.2 million in FY2023 and a low of $796,800 during FY2020.
- Moreover, its 3-year median value for Operating Expenses was $26.6 million (2022), whereas its average is $24.4 million.
- As far as peak fluctuations go, Mainz Biomed N.V's Operating Expenses soared by 1,142.75% in 2021, and later dropped by 29.03% in 2024.
- Over the past 5 years, Mainz Biomed N.V's Operating Expenses (Yearly) stood at $796,800 in 2020, then soared by 1,142.75% to $9.9 million in 2021, then surged by 168.89% to $26.6 million in 2022, then rose by 1.98% to $27.2 million in 2023, then dropped by 29.03% to $19.3 million in 2024.